Evidence map›Paper›PMID 39664649›Full record

ArticlePsychiatry research communications2024

Patient perceptions of lisdexamfetamine as a treatment for binge eating disorder: An exploratory qualitative and quantitative analysis.

Abanoub J Armanious, Audrey Asare, Deborah Mitchison, Morgan H James

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Psychiatry research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. International journal of molecular sciences · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abanoub J ArmaniousDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, 08854, USA.
Audrey AsareDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, 08854, USA.
Deborah MitchisonDiscipline of Clinical Psychology, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia.
Morgan H JamesDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, 08854, USA.

Funding

Translational Research Support CoreP30ES005022 · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · 1988 to 2025
$12.3M
Orexin (hypocretin) signaling in ventral tegmental area as a common mediator of sleep disturbances and drug demand in cocaine abstinenceR01DA061303 · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · 2025 to 2025
$373k
The orexin system as a novel mediator of depression-like outcomes in female rats exposed to an endocrine disrupting compound during the peripubertal periodR21ES035848 · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · 2025 to 2025
$196k
NHLBI NIH HHS U01 HL150852NIDA NIH HHS R00 DA045765NIDA NIH HHS R01 DA061303NIDA NIH HHS R37 DA061303NIEHS NIH HHS P30 ES005022NIEHS NIH HHS R21 ES035848
6 · The paper itself

Abstract

Lisdexamfetamine (LDX) is the only medication to have gained FDA approval for the treatment of binge eating disorder (BED). LDX treatment is generally effective at reducing binge eating symptoms but is associated with several unwanted side effects. How BED patients perceive the therapeutic efficacy vs. associated side effects of LDX has not been explored. We carried out a thematic analysis of 111 online reviews posted to the website Drugs. com by persons prescribed LDX to treat BED. We also explored how qualitative themes were associated with perceptions of treatment efficacy on a quantitative (1-10 scale) scale. Themes associated with higher efficacy ratings included improved binge eating outcomes, enhanced focus/concentration, as well as weight loss (χ

Indexed as

Bulimia nervosaDiscussion boardEating disordersPharmacotherapyQualitativeSleepThematic analysis

Identifiers

PMID39664649
PMCPMC11633666

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.